{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T03:51:16Z","timestamp":1703649076757},"reference-count":0,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2003,10,2]],"date-time":"2003-10-02T00:00:00Z","timestamp":1065052800000},"content-version":"vor","delay-in-days":2161,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[1997,11]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Symptom relief and endoscopic healing are both important treatment goals in patients with reflux oesophagitis. Knowledge of predictive factors for treatment success could facilitate choice of treatment in individual patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim:<\/jats:title><jats:p>To assess the value of clinical data and data from baseline ancillary investigations in predicting the outcome of maintenance therapy with a proton pump inhibitor.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>After healing and symptom relief had been obtained on open therapy with lansoprazole 30\u2003mg daily, 103 patients with reflux oesophagitis grade 1 or 2 were randomized to maintenance therapy with lansoprazole 15 or 30\u2003mg daily, and time until recurrence of symptoms and\/or endoscopic changes was recorded. The predictive value of the following variables was assessed by Cox regression analysis: dose of lansoprazole, symptom severity, grade of reflux oesophagitis, <jats:italic>Helicobacter pylori<\/jats:italic> infection status, lower oesophageal sphincter resting tone, percentage of 24\u2003h with an oesophageal pH of\u2003&lt;4.0, and median 24\u2003h intragastric pH before start of treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Dose of lansoprazole (<jats:italic>P<\/jats:italic>\u2003=\u20030.01) and symptom severity (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05) both significantly predicted time to relapse. Grade of reflux oesophagitis had only a borderline predictive value (<jats:italic>P<\/jats:italic>\u2003=\u20030.09), while <jats:italic>H. pylori<\/jats:italic> infection status and data from manometry and intraoesophageal 24\u2010hour pH\u2010metry did not predict relapse.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>Symptom severity before starting therapy is a significant predictive factor for treatment success during potent antisecretory therapy with lansoprazole, more so than endoscopic grade of reflux oesophagitis. In a group of patients with uncomplicated reflux oesophagitis being considered for maintenance therapy with lansoprazole, ancillary investigations with endoscopy, manometry and 24\u2010hour pH\u2010metry gave very limited prognostic information. <jats:italic>H. pylori<\/jats:italic> infected patients relapsed as early as patients who were not infected.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.1997.00246.x","type":"journal-article","created":{"date-parts":[[2003,10,15]],"date-time":"2003-10-15T02:56:37Z","timestamp":1066186597000},"page":"1093-1099","source":"Crossref","is-referenced-by-count":30,"title":["Prognostic factors for relapse of reflux oesophagitis and symptoms during 12\u2003months of therapy with lansoprazole"],"prefix":"10.1111","volume":"11","author":[{"given":"J. G.","family":"HATLEBAKK","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"BERSTAD","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,10,2]]},"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.1997.00246.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.1997.00246.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T06:01:02Z","timestamp":1698472862000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.1997.00246.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,11]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1997,11]]}},"alternative-id":["10.1046\/j.1365-2036.1997.00246.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.1997.00246.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,11]]}}}